NEW YORK, July 29 (GenomeWeb News) - Sequenom announced today that it has terminated its internal drug discovery efforts and will shut down its pharmaceuticals business unit in an effort to focus on its genetics systems business unit.
...and receive Daily News bulletins.
Already have an account?Login Now.
The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.
A small study finds differences between three genomic prostate cancer tests, Medscape reports.
In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.
A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.